MedKoo Biosciences, Inc.
Tel:   +1-919-636-5577    Fax:   +1-919-980-4831    Email:   sales@medkoo.com
Search
Login Register
Search
MedKoo Cat#: 596973 | Name: SDZ204-090

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Sdz 204-090 is a cyclic octapeptide analog of somatostatin.

Chemical Structure

SDZ204-090
SDZ204-090
CAS#96608-80-9

Theoretical Analysis

MedKoo Cat#: 596973

Name: SDZ204-090

CAS#: 96608-80-9

Chemical Formula: C49H66N10O11S2

Exact Mass: 1034.4354

Molecular Weight: 1035.24

Elemental Analysis: C, 56.85; H, 6.43; N, 13.53; O, 17.00; S, 6.19

Price and Availability

This product is currently not in stock but may be available through custom synthesis. To ensure cost efficiency, the minimum order quantity is 1 gram. The estimated lead time is 2 to 4 months, with pricing dependent on the complexity of the synthesis (typically high for intricate chemistries). Quotes for quantities below 1 gram will not be provided. To request a quote, please click the button below. Note: If this product becomes available in stock in the future, pricing will be listed accordingly.
Bulk Inquiry
Related CAS #
No Data
Synonym
Sdz 204-090; Sdz-204-090; Sdz204-090; Sdz 204090; Sdz-204090; Sdz204090; SDZ 204-090; SMS 204-090; Sandoz 204-090; TOC; Tyr3-octreotide; [Tyr3]SMS-(201-995);
IUPAC/Chemical Name
(4R,7R,10S,13R,16S,19R)-13-((1H-indol-3-yl)methyl)-19-((S)-2-amino-3-phenylpropanamido)-10-(4-aminobutyl)-N-((2S,3S)-1,3-dihydroxybutan-2-yl)-16-(4-hydroxybenzyl)-7-((R)-1-hydroxyethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentaazacycloicosane-4-carboxamide
InChi Key
LHCIROHUTQLZCZ-VJVIEHPVSA-N
InChi Code
InChI=1S/C49H66N10O11S2/c1-27(61)39(24-60)56-48(69)41-26-72-71-25-40(57-43(64)34(51)20-29-10-4-3-5-11-29)47(68)54-37(21-30-15-17-32(63)18-16-30)45(66)55-38(22-31-23-52-35-13-7-6-12-33(31)35)46(67)53-36(14-8-9-19-50)44(65)59-42(28(2)62)49(70)58-41/h3-7,10-13,15-18,23,27-28,34,36-42,52,60-63H,8-9,14,19-22,24-26,50-51H2,1-2H3,(H,53,67)(H,54,68)(H,55,66)(H,56,69)(H,57,64)(H,58,70)(H,59,65)/t27-,28+,34-,36-,37-,38+,39-,40-,41-,42+/m0/s1
SMILES Code
O=C([C@@H](NC([C@@H]([C@H](O)C)NC([C@H](CCCCN)NC([C@@H](CC1=CNC2=C1C=CC=C2)NC([C@H](CC3=CC=C(O)C=C3)N4)=O)=O)=O)=O)CSSC[C@H](NC([C@@H](N)CC5=CC=CC=C5)=O)C4=O)N[C@H]([C@@H](O)C)CO
Appearance
Solid powder
Purity
>98% (or refer to the Certificate of Analysis)
Shipping Condition
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility
Soluble in DMSO
Shelf Life
>2 years if stored properly
Drug Formulation
This drug may be formulated in DMSO
Stock Solution Storage
0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code
2934.99.9001
More Info

Preparing Stock Solutions

The following data is based on the product molecular weight 1,035.24 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
1: Beckers A, Pham VT, Abs R, Foidart-Willems J, Meurisse M. [Scintigraphic localization of neuroendocrine tumors and their metastases using a somatostatin analog [111In-DTPA-d-phe1] octreotide]. Rev Med Liege. 1993 Jun 1;48(6):326-34. Review. French. PubMed PMID: 8101999. 2: Bruns C, Stolz B, Albert R, Marbach P, Pless J. OctreoScan 111 for imaging of a somatostatin receptor-positive islet cell tumor in rat. Horm Metab Res Suppl. 1993;27:5-11. PubMed PMID: 8392488. 3: Krenning EP, Bakker WH, Kooij PP, Breeman WA, Oei HY, de Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ, et al. Somatostatin receptor scintigraphy with indium-111-DTPA-D-Phe-1-octreotide in man: metabolism, dosimetry and comparison with iodine-123-Tyr-3-octreotide. J Nucl Med. 1992 May;33(5):652-8. PubMed PMID: 1349039. 4: Faglia G, Bazzoni N, Spada A, Arosio M, Ambrosi B, Spinelli F, Sara R, Bonino C, Lunghi F. In vivo detection of somatostatin receptors in patients with functionless pituitary adenomas by means of a radioiodinated analog of somatostatin ([123I]SDZ 204-090). J Clin Endocrinol Metab. 1991 Oct;73(4):850-6. PubMed PMID: 1653785. 5: Pantev T, Virgolini I, Neuhold N, Angelberger P, Luger A, Sinzinger H. Evaluation of somatostatin receptors in human cancer. Wien Klin Wochenschr. 1991;103(21):649-53. PubMed PMID: 1663300. 6: Mackie EJ, Trechsel U, Bruns C. Somatostatin receptors are restricted to a subpopulation of osteoblast-like cells during endochondral bone formation. Development. 1990 Dec;110(4):1233-9. PubMed PMID: 1712702. 7: Bruns C, Dietl MM, Palacios JM, Pless J. Identification and characterization of somatostatin receptors in neonatal rat long bones. Biochem J. 1990 Jan 1;265(1):39-44. PubMed PMID: 1967933; PubMed Central PMCID: PMC1136611.